A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations
Key Finding
Bacopa monnieri progressively improved memory consolidation and learning over 12 weeks in older adults.
Plain-English Summary
This randomized, double-blind, placebo-controlled trial examined Bacopa monnieri in 81 healthy older adults (age 55+) over 12 weeks. Participants received 300mg of standardized bacopa extract daily or placebo.
The bacopa group demonstrated significant improvements in verbal learning, memory consolidation, and information retention compared to placebo. Effects became progressively more pronounced over the 12-week period, with the greatest benefits observed at week 12.
Participants also showed improvements in attention and reduced anxiety. The study used rigorous cognitive testing including the Auditory Verbal Learning Test and showed that bacopa enhanced the rate of learning and reduced forgetting. These findings confirm that bacopa requires chronic administration to produce cognitive benefits, likely due to its effects on neuronal structure and synaptic communication rather than acute neurotransmitter effects. Bacopa was well-tolerated throughout the study.